This treatment plan is limited to a single patient with Congenital Myotonic Dystrophy, who is ineligible or otherwise unable to participate in ongoing clinical trials.
Study Type
EXPANDED_ACCESS
Harriet Gray-Stephens, BM BCh, MA (Oxon), MFPM
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.